l-carnitine dosage with mitochondrial disease Carnitine Deficiency: What Is It, Causes, Symptoms, and More L-Carnitine and Acylcarnitines: Mitochondrial Biomarkers
Description
FDA approves first drug for Parkinson disease psychosis
ISSN 0023-2173
Intr-un mod mai simplu, putem considera ca l-carnitina favorizeaza transformarea grasimilor in energie
Serra G, Antona V, Schierz M, Vecchio D, Piro E, Corsello G
Our results demonstrated that the p70S6K and p-p70S6K levels were increased by L-carnitine treatment in a time-dependent manner (Fig
J Neurochem 85: 11011108, 2003
